| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | 3.428 | 8.942 | 12.652 | 17.687 | 10.178 | 20.876 | 29.315 |
| Total Income - EUR | 0 | 0 | - | 3.428 | 8.945 | 12.652 | 17.687 | 10.178 | 20.876 | 29.315 |
| Total Expenses - EUR | 0 | 0 | - | 1.936 | 8.308 | 10.645 | 22.596 | 8.830 | 19.754 | 20.021 |
| Gross Profit/Loss - EUR | 0 | 0 | - | 1.492 | 637 | 2.007 | -4.909 | 1.347 | 1.122 | 9.294 |
| Net Profit/Loss - EUR | 0 | 0 | - | 1.389 | 368 | 1.819 | -5.408 | 1.183 | 913 | 9.007 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Genes Safir S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 547 | 4.934 | 6.712 | 5.749 | 4.822 | 6.143 |
| Current Assets | 0 | 0 | - | 3.763 | 3.204 | 4.497 | 295 | 4.816 | 14.670 | 25.365 |
| Inventories | 0 | 0 | - | 2.108 | 2.194 | 4.203 | 0 | 3.496 | 12.258 | 22.303 |
| Receivables | 0 | 0 | - | 1.123 | 418 | 294 | 222 | 223 | 412 | 2.504 |
| Cash | 0 | 0 | - | 532 | 592 | 0 | 73 | 1.097 | 1.999 | 557 |
| Shareholders Funds | -1.831 | -1.812 | - | -360 | 15 | 1.834 | -3.614 | -2.442 | -1.522 | 3.171 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.831 | 1.812 | - | 4.122 | 3.736 | 7.597 | 10.622 | 13.537 | 21.014 | 28.421 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Genes Safir S.r.l.